Monthly Archives: November 2012
By Julian Upton | Published: November 14, 2012
Greece took its part on Wednesday in the latest widespread strikes against austerity measures that swept across Europe, throwing travel networks into disarray and sparking violent clashes between police and workers. But for once Greece wasn’t at the forefront of the misery as the country has been thrown a couple more lifelines — not least [...]
By Guest Blogger | Published: November 14, 2012
By Amy Ritter. In the wake of the meningitis outbreak caused by contaminated compounded medications produced by the New England Compounding Center (NECC), both the government and the public have been wrestling with the question of how this happened — how did a company producing substandard medicines slip through regulatory oversight?
By Guest Blogger | Published: November 12, 2012
The abrupt departure of Europe’s health commissioner continues to resonate across the European Union – and to leave plans for new clinical trials legislation without a patron, writes Peter O’ Donnell of Applied Clinical Trials. John Dalli, the former Maltese finance minister, was forced out of his job as Europe’s health supremo in mid-October, over suggestions [...]
By Guest Blogger | Published: November 7, 2012
by Tom Norton With the Presidential election decided and President Obama the clear winner, it’s time for Pharma to get down to business on the implementation of ObamaCare. Here are some of the key actions to anticipate between now and January 1, 2013.
By Ben Comer | Published: November 7, 2012
Patients in search of face time with a healthcare provider are stopping into their local drugstores, where consultations are free and the wait time is shorter. Pharmacists are in a unique position, too, to move the needle on drug adherence.